Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard N Channick

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Chest|August 18, 2020
Sex Differences in Portopulmonary HypertensionHilary M DuBrock, Rodrigo Cartin-Ceba, Richard N Channick, et al.
The New England Journal of Medicine|March 21, 2014
Case records of the Massachusetts General Hospital. Case 9-2014. A 34-year-old woman with increasing dyspneaKai Saukkonen, Timothy C Tan, Amita Sharma, et al.
Pulmonary Circulation|August 6, 2024
Immature reticulocyte fraction: A novel biomarker of hemodynamic severity in pulmonary arterial hypertensionAdam J Brownstein, Jared D Wilkinson, Lloyd L Liang, et al.
American Journal of Respiratory and Critical Care Medicine|February 20, 2020
Free-Floating Right Atrial Thrombus Removed by Aspiration Thrombectomy under Transesophageal GuidanceAlexander E Sherman, John M Moriarty, Eric H Yang, et al.
Chest|August 23, 2008
Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertensionKelly M Chin, Richard N Channick, James A de Lemos, et al.
The Annals of Thoracic Surgery|July 5, 2003
Decreased plasma neurohormones and improved cardiac performance after surgical treatment of chronic pulmonary embolismIgor I Tulevski, Paul Bresser, Alexander Hirsch, et al.
Annals of Diagnostic Pathology|January 29, 2013
Postradiofrequency ablation inflammatory pseudotumor associated with pulmonary venoocclusive disease: case report and review of the literatureAlexandra E Kovach, George Z Cheng, Colleen L Channick, et al.
Chest|July 11, 2003
Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up studyOlivier Sitbon, David B Badesch, Richard N Channick, et al.
Pulmonary Circulation|September 29, 2022
Using a knowledge translation program to facilitate guideline- and evidence-based patient management: the PAH-QuERI Extension ProgramVallerie V McLaughlin, Richard N Channick, Karimah S Bell Lynum, et al.
Chest|August 23, 2012
Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gapVallerie V McLaughlin, Anatoly Langer, Mary Tan, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Chest|August 18, 2020
Sex Differences in Portopulmonary HypertensionHilary M DuBrock, Rodrigo Cartin-Ceba, Richard N Channick, et al.
The New England Journal of Medicine|March 21, 2014
Case records of the Massachusetts General Hospital. Case 9-2014. A 34-year-old woman with increasing dyspneaKai Saukkonen, Timothy C Tan, Amita Sharma, et al.
Pulmonary Circulation|August 6, 2024
Immature reticulocyte fraction: A novel biomarker of hemodynamic severity in pulmonary arterial hypertensionAdam J Brownstein, Jared D Wilkinson, Lloyd L Liang, et al.
American Journal of Respiratory and Critical Care Medicine|February 20, 2020
Free-Floating Right Atrial Thrombus Removed by Aspiration Thrombectomy under Transesophageal GuidanceAlexander E Sherman, John M Moriarty, Eric H Yang, et al.
Chest|August 23, 2008
Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertensionKelly M Chin, Richard N Channick, James A de Lemos, et al.
The Annals of Thoracic Surgery|July 5, 2003
Decreased plasma neurohormones and improved cardiac performance after surgical treatment of chronic pulmonary embolismIgor I Tulevski, Paul Bresser, Alexander Hirsch, et al.
Annals of Diagnostic Pathology|January 29, 2013
Postradiofrequency ablation inflammatory pseudotumor associated with pulmonary venoocclusive disease: case report and review of the literatureAlexandra E Kovach, George Z Cheng, Colleen L Channick, et al.
Chest|July 11, 2003
Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up studyOlivier Sitbon, David B Badesch, Richard N Channick, et al.
Pulmonary Circulation|September 29, 2022
Using a knowledge translation program to facilitate guideline- and evidence-based patient management: the PAH-QuERI Extension ProgramVallerie V McLaughlin, Richard N Channick, Karimah S Bell Lynum, et al.
Chest|August 23, 2012
Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gapVallerie V McLaughlin, Anatoly Langer, Mary Tan, et al.
Pageof 11